Basal cell carcinoma (BCC) is the most common skin malignancy, accounting for up to 80% of all cancers arising from the epidermis.1 The disease usually presents as a slow growing, non-healing raised lesion with rolled borders and telangiectasias. These cancers arise from cells lining the deepest layer of the epidermis. BCC affects approximately 1 million Americans each year, more than squamous cell carcinoma and melanoma combined.2 It is most commonly diagnosed in older, fair skinned individuals from ages 40-60.3 Large amounts of sun exposure and UV radiation are the most common cause of BCC. Other etiologies include arsenic and various genetic disorders such as Nevus Sebaceous of Jadassohn, Xeroderma Pigmentosum, Basal Cell Nevus syndrome, Bazex syndrome, and Rombo syndrome.